Sciegen Pharmaceuticals Inc recalls GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx

Recalled November 28, 2018 · FDA recall D-0271-2019 · Sciegen Pharmaceuticals

Hazard

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product. · FDA Class II

Units

18,760 HDPE bottles

Sold at

Nationwide

Description

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Product

GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.

Manufacturer(s)

Sciegen Pharmaceuticals Inc

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →